Host genetic variation contributes to phenotypic diversity in myeloproliferative disorders

Animesh Pardanani1, Brooke L Fridley, Terra L Lasho

  • 1Division of Hematology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. pardanani.animesh@mayo.edu

Blood
|November 17, 2007
PubMed

Insights

Host genetic variations influence myeloproliferative disorders. Specific JAK2 and EPOR single nucleotide polymorphisms are associated with distinct clinical phenotypes like polycythemia vera and essential thrombocythemia, but not primary myelofibrosis.

Area of Science:

  • Hematology
  • Genetics
  • Oncology

Background:

  • The JAK2V617F mutation is linked to polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF).
  • The presence of a single mutation associated with diverse clinical outcomes suggests the involvement of host-modifying factors.
  • Investigating genetic variations in key signaling pathways may elucidate this phenotypic variability.

Purpose of the Study:

  • To test the hypothesis that host genetic variations contribute to the distinct clinical phenotypes observed in myeloproliferative disorders (MPNs) associated with the JAK2V617F mutation.
  • To identify specific genetic variations within JAK-STAT signaling pathway genes that correlate with different MPN phenotypes.

Main Methods:

  • Genotyping of 32 single nucleotide polymorphism (SNP) loci in JAK2, EPOR, MPL, and GCSFR genes.
  • Analysis of genotype-phenotype correlations in 179 white patients with PV, PMF, or ET.
  • Statistical analysis including odds ratios and p-values to assess SNP associations with specific MPN diagnoses.

Main Results:

  • Three JAK2 SNPs (rs7046736, rs10815148, rs12342421) showed significant, reciprocal associations with PV and ET, but not PMF.
  • Three additional JAK2 SNPs (rs10758669, rs3808850, rs10974947) and one EPOR SNP (rs318699) were associated with PV exclusively.
  • Intragenic JAK2 haplotypes were significantly associated with PV, further supporting a genetic influence on disease phenotype.

Conclusions:

  • Host genetic variations, particularly within JAK2 and EPOR, play a role in determining the clinical phenotype of myeloproliferative disorders.
  • These genetic factors may explain the phenotypic diversity observed among patients with the shared JAK2V617F mutation.
  • The findings highlight the importance of considering host genetics in understanding the pathogenesis and clinical presentation of MPNs.

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Genetic Variation01:25

Genetic Variation

Genetic variation is the diversity in DNA sequences found among individuals of the same species. This diversity is crucial for a species' survival because it helps organisms adapt to environmental changes. Genetic variation begins with fertilization, where an egg and sperm cell merge. Each of these cells carries 23 chromosomes, up to 46 in the fertilized egg. Chromosomes are long DNA strands that contain genes, the basic units of heredity.
Genes exist in different versions called alleles, which...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Mutation, Gene Flow, and Genetic Drift01:09

Mutation, Gene Flow, and Genetic Drift

In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).Mechanisms of Genetic VariationThe original sources of genetic variation are mutations,...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism